Focus Stocks
Eli Lilly Formed a Tweezer Top
Published on Tuesday, 08 January 2013 04:39 Written by TradersHuddle Wire
New York, January 8th (TradersHuddle.com) - Eli Lilly & Co. (NYSE:LLY) closed the trading session higher by $1.84 or 3.7% from its previous close. The latest price action developed a short term reversal pattern in the form of a tweezer top, which is a
candlestick pattern that is usually formed at the end of an uptrend. Given that the tweezer top is considered a reversal pattern, traders with long positions need to monitor the price action for confirmation of weakness, and plan the position accordingly.
Eli Lilly (NYSE:LLY) principal activities are to develop, manufacture and market pharmaceutical-based health care solutions. The company specializes in research and development, production and marketing of products for the treatment of diabetes worldwide, such as insulin and insulin delivery devices.. Some of the company's patents include Zyprexa, Prozac, Permax, Humulin, Evista, Humalog, Humatrope, Vancocin, Keflex, Nebcin , Lorabid, Gemzar, Tylan, and Rumensin.
Eli Lilly's stock has been in a defined range with calculated support at $47.61 and resistance at $50.76. Given the possibility of short-term weakness in the stock's price, this range could be used by traders managing their positions.
Tweezer tops are exactly the opposite of tweezer bottoms, as they define a resistance point for Eli Lilly that needs to be digested prior for the stock to move to a higher level.
Tweezer tops can be formed at the end of an uptrend, at a clear horizontal resistance point, or within a downtrend when price action is dealing with the declining resistance trend. Like any other candlestick pattern, it needs confirmation by trading below the previous day low. Below there is an example of the Tweezer Top reversal pattern:

Related Articles
- From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients
- Lilly Oncology to Release New Pipeline Data at ASCO 2013
- Lilly Provides Update on CEO Dr. John Lechleiter
- Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
- Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
- Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
- Lilly Declares Second-Quarter 2013 Dividend
- Critical Alerts For Microsoft, Suncor Energy, Eli Lilly, TRW Automotive, and Embraer Released By InvestorsObserver
- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
- The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small
Related Partner Headlines
- Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY) - TheStreet.com
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY) - TheStreet.com
- Lilly to Present Phase II Rheumatoid Arthritis and Biomarker Data at ACR For Two Investigational Medicines to Treat Autoimmune Diseases - Benzinga
- Eli Lilly And Company (LLY): Today's Featured Drugs Laggard - TheStreet.com
- Eli Lilly: Bearish Optons Trade - TheStreet.com
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY) - TheStreet.com
- Lilly to Announce Expansion of Indianapolis Insulin Manufacturing Operations - Benzinga
- European Commission Approves Lilly's Cialis for Benign Prostatic Hyperplasia - Benzinga
- Eli Lilly And Company (LLY): Today's Featured Drugs Laggard - TheStreet.com
- UPDATE: Eli Lilly Posts Downbeat Q3 Profit - Benzinga
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,335.28 Trade time:4:36PM EDT Value change:▼19.12 (-0.12%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,666.29 Trade time:4:36PM EDT Value change:▼1.18 (-0.07%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,496.43 Trade time:5:15PM EDT Value change:▼2.54 (-0.07%)In The Wires
-
Verrata™ Pressure Guide Wire and iFR® (Instant Wave-Free Ratio™) Software Modality will be on display at EuroPCR 2013[1] -
SAP to Work With Specialisterne to Employ People With Autism -
Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system -
GigaMedia's Cloud Business Hits New Strategic Milestone: Expansion Into Government Sector -
TBdress.com Is Launching a Promotion of Quinceanera Dresses -
Cheap Car Insurance - Compare Over 40 Quotes and Save $600 -
Monster Energy Team Smash It Again In Best Whip At X Games Barcelona 2013 -
Truck Accident Attorney Notes Steady Increase In Litigation Cases








